{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/fibroids/how-up-to-date-is-this-topic/changes/","result":{"pageContext":{"chapter":{"id":"f79d0226-1517-5e54-aab7-8835d760b8cc","slug":"changes","fullItemName":"Changes","depth":2,"htmlHeader":"<!-- begin field 8a07495a-e99e-4a9b-b54c-20fc66196b90 --><h2>Changes</h2><!-- end field 8a07495a-e99e-4a9b-b54c-20fc66196b90 -->","summary":null,"htmlStringContent":"<!-- begin item 4d217e5d-bc24-4206-a5e7-dc7e0540a7ba --><!-- begin field b7b6bf13-becc-4394-9ba1-4f7416c4bb8a --><p><strong>December 2018 </strong>— minor update. The recommendations on managing women with menorrhagia associated with fibroids have been removed and replaced with a link to the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/menorrhagia/\">Menorrhagia</a>. The information on the secondary care management of fibroids has also been removed as it is outside the scope of this CKS topic.</p><p><strong>March 2018 </strong>— minor update. The advice from the European Medicines Agency relating to ulipristal (Esmya) has been added. </p><p><strong>June to July 2017 </strong>— reviewed. A literature search was conducted in June 2017 to identify evidence-based guidelines, UK policy, systematic reviews, and key randomized controlled trials published since the last revision of the topic. </p><!-- end field b7b6bf13-becc-4394-9ba1-4f7416c4bb8a --><!-- end item 4d217e5d-bc24-4206-a5e7-dc7e0540a7ba -->","topic":{"id":"6463a640-e4df-5049-8bb4-6654ab8b15ce","topicId":"3fd67974-f2c5-44ed-822f-084a7bfa2b77","topicName":"Fibroids","slug":"fibroids","lastRevised":"Last revised in December 2018","chapters":[{"id":"17b509af-8275-5623-a47b-ec3301ad1e00","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"dd45c961-3e46-592b-93bd-04eac254ce78","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"cc8303eb-62bc-5f8f-b697-83157c2c4fe7","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"f79d0226-1517-5e54-aab7-8835d760b8cc","slug":"changes","fullItemName":"Changes"},{"id":"767a9892-20df-5979-bed9-cffded6848c6","slug":"update","fullItemName":"Update"}]},{"id":"7b24582e-8917-5b59-a8bf-73b8769a2e86","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"96c90f71-050c-59fa-aedc-953048783302","slug":"goals","fullItemName":"Goals"},{"id":"e4a2aeb9-62f9-58bb-a248-c1dc9358b254","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"1666f790-8ff1-5ba8-95de-23a735364bc8","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"f35cbfa6-b4fc-574b-8eb6-7df9e8070976","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"c597adf8-a842-51ae-88e6-441cacfbdfc9","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"f1a497a7-9324-5e43-bc01-3b33e344ff83","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"18d5fa10-3213-5357-9062-7b0e16a0a785","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"38f26131-0aa0-5700-a6fd-25bd7a26503a","slug":"definition","fullItemName":"Definition"},{"id":"ee0338f8-7167-58f0-8c50-1aab97a3b27e","slug":"prevalence","fullItemName":"Prevalence"},{"id":"709492e8-0053-5ca6-8a20-ddfabff85694","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"b7f5350a-2c61-535b-bb44-cd9c51132b57","slug":"natural-history-of-fibroids","fullItemName":"Natural history of fibroids"},{"id":"e3765a3b-c1e7-5221-acb7-cc000b1de1c5","slug":"complications","fullItemName":"Complications"}]},{"id":"3c5ed9b8-5b6d-5b68-8d15-b9e7b15a8d1d","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"b98686e1-b4a2-5937-9e77-a1aa76faec11","slug":"assessment","fullItemName":"Assessment"},{"id":"137f352c-c6be-56ed-bfaf-8627d692a159","slug":"signs-symptoms","fullItemName":"Signs and symptoms"},{"id":"0a19e969-b9fc-5a47-99d1-f81fa33bfcc2","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"26643766-7cf9-532d-8dc9-a1ca4a679b5c","fullItemName":"Management","slug":"management","subChapters":[{"id":"0dcebc15-0b4a-5898-9e9d-bdce5879ed3d","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"16c07bd4-71e3-573e-a85f-190156235c98","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"4bbe6ec3-6612-56ee-bd5d-3bac8fc870aa","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"eec2e9fc-14b3-52df-b3f8-853d2bd020c1","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"f9855d83-db65-5e68-b06a-bfd8533e2b6b","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"8a30e797-0317-501c-96a6-0c96f08d306e","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"94bd4428-5492-5e06-854c-3f6747917258","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"41c7124d-fd7d-5771-9ef3-cff4588a2f3b","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"a166d27d-9883-5200-a62f-532b916906ea","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"cc8303eb-62bc-5f8f-b697-83157c2c4fe7","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?"},"subChapters":[{"id":"e7dd06d2-788f-595b-bd7d-52acf6b59c42","slug":"previous-changes","fullItemName":"Previous changes","depth":3,"htmlHeader":"<!-- begin field 76659157-a91e-4a2b-a08b-aaa5e0d77eed --><h3>Previous changes</h3><!-- end field 76659157-a91e-4a2b-a08b-aaa5e0d77eed -->","summary":null,"htmlStringContent":"<!-- begin item 04cabed4-8ddd-4737-ba19-034a7776804a --><!-- begin field b44ca22c-0d7c-442e-b723-eabc5e73b2fb --><p><strong>February 2013 </strong>— reviewed. A literature search was conducted in January 2013 to identify evidence-based guidelines, UK policy, systematic reviews, and key RCTs published since the last revision of the topic. Recommendations regarding expectant management, and the management of menorrhagia associated with fibroids have been added.</p><p><strong>August to December 2009 </strong>— this is a new CKS topic. The evidence-base has been reviewed in detail, and recommendations are clearly justified and transparently linked to the supporting evidence.</p><!-- end field b44ca22c-0d7c-442e-b723-eabc5e73b2fb --><!-- end item 04cabed4-8ddd-4737-ba19-034a7776804a -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}